Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inotuzumab ozogamicin is an effective salvage therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with high-risk molecular features, including TP53 loss
    Meeting Abstract

    Yang, X.; King, A. C.; Kabel, C. C.; Forlenza, C. J.; Park, J. H.; Geyer, M. B.
    Blood (2019)

    Fulltext@MSK | Save
  • Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: A retrospective analysis of real world patients
    Meeting Abstract

    Yazdy, M. S.; Mato, A. R.; Roeker, L. E.; Jarral, U.; Ujjani, C. S.; Shadman, M.; Skarbnik, A.; Whitaker, K. J.; Deonarine, I.; Kabel, C. C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A prospective disease registry of patients with mantle cell lymphoma treated with novel agents: Treatment patterns, outcomes, and patient-reported health-related quality of life
    Meeting Abstract

    Ujjani, C.; Mato, A. R.; Cohen, J. B.; Svoboda, J.; Andorsky, D.; Goy, A.; Wang, M. L.; Kumar, A.; Torney, P. A.; Dawson, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • The genetic architecture of myeloproliferative neoplasms-blast phase (MPN-BP) stem cells
    Meeting Abstract

    Wang, X.; Rampal, R. K.; Hu, C. S.; Farnoud, N.; Famulare, C.; Patel, M. A.; McGovern, E.; Hoffman, R.
    Blood (2019)

    Fulltext@MSK | Save
  • Tolerability and efficacy of crenolanib and cytarabine/anthracycline chemotherapy in older patients (aged 61 to 75) with newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
    Meeting Abstract

    Wang, E. S.; Griffiths, E. A.; Walter, R. B.; Tallman, M. S.; Goldberg, A. D.; Messahel, B.; Stone, R. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients
    Meeting Abstract

    Ujjani, C. S.; Roeker, L. E.; Shadman, M.; Whitaker, K. J.; Jacob, A. P.; Geyer, M. B.; Dorsey, C.; Zelenetz, A. D.; Mato, A. R.
    Blood (2019)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: A SEER-Medicare analysis
    Meeting Abstract

    Stein, E. M.; Latremouille-Viau, D.; Joseph, G. J.; Shi, S.; Guerin, A.; Wu, E. Q.; Bonifacio, G.; Cao, X.
    Blood (2019)

    Fulltext@MSK | Save
  • Annotation of somatic genomic variants in hematologic diseases using OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Roshal, M.; Xiao, W.; Petrova-Drus, K.; Yabe, M.; Ho, C.; Zhang, H.; Knorr, D.; Miles, L. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Treatment discontinuation patterns for patients with CLL in the real-world settings: Results from a multi-center study
    Meeting Abstract

    Shadman, M.; Sail, K.; Manzoor, B. S.; Yazdy, M. S.; Hill, B. T.; Tuncer, H. H.; Allan, J. N.; Ujjani, C. S.; Emechebe, N.; Kamalakar, R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Timing for allogeneic hematopoietic stem cell transplantation (HSCT) in chronic myelomonocytic leukemia (CMML): A joint study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT
    Meeting Abstract

    Robin, M.; de Wreede, L. C.; Padron, E.; Wang, J.; Hazelaar, S.; Beelen, D. W.; Fenaux, P.; Bornhàˆuser, M.; Kroeger, N.; Nazha, A.; more...
    Blood (2019)

    Fulltext@MSK | Save